By NewsDesk  @bactiman63 Seqirus announced this week that the U.S. Food and Drug Administration (FDA) has approved FLUCELVAX® QUADRIVALENT (Influenza Vaccine), the company’s cell-based quadrivalent...

On Saturday, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory...

Pfizer Inc. recently announced that the U.S. Food and Drug Administration (FDA) accepted for Priority Review the company’s Biologics License Application (BLA) for TicoVac™, its tick-borne encephalitis...

More U.S. adults reported receiving or planning to receive an influenza vaccination during the 2020-2021 flu season than ever before, according to findings from a national survey. The survey of 1,027...

Biotechnology company, INOVIO, announced the first participant was dosed in a Phase 1B clinical trial for INO-4500, its DNA vaccine candidate for Lassa fever, in Ghana. The Phase 1B clinical trial...

By NewsDesk  @bactiman63 The Cuban Ministry of Health (Ministerio de Salud Pública de la República de Cuba) announced today that a polio vaccination campaign will begin Monday. From February 22 to...

By NewsDesk  @bactiman63 In Chile, a total of 2,818,147 people have been vaccinated against COVID-19 through Friday. 1,706,483 adults over 65 have been inoculated, according to data provided by the Department...

By NewsDesk  @bactiman63 The Ministry of Health (Minsa) projects that by July of this year there will be enough vaccines against COVID-19 to apply to 61% of the elderly residents in the country, informed...

Under the Biden Administration, New Yorkers’ acceptance of the Covid-19 vaccine has increased significantly. In September, 55% of residents reported they would take the vaccine when it became available...

A vaccine for use against the deadly Nipah and Hendra viruses has demonstrated effectiveness in preclinical studies as early as 7 days following a single immunization, according to a new study, “A...